Related Experiment Video
Updated: Mar 17, 2026
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
FocalScan: Scanning for altered genes in cancer based on coordinated DNA and RNA change
Joakim Karlsson1, Erik Larsson2
1Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
Abstract:
Somatic genomic copy-number alterations can lead to transcriptional activation or inactivation of tumor driver or suppressor genes, contributing to the malignant properties of cancer cells. Selection for such events may manifest as recurrent amplifications or deletions of size-limited (focal) regions. While methods have been developed to identify such focal regions, finding the exact targeted genes remains a challenge. Algorithms are also available that integrate copy number and RNA expression data, to aid in identifying individual targeted genes, but specificity is lacking. Here, we describe FocalScan, a tool designed to simultaneously uncover patterns of focal copy number alteration and coordinated expression change, thus combining both principles. The method outputs a ranking of tentative cancer drivers or suppressors. FocalScan works with RNA-seq data, and unlike other tools it can scan the genome unaided by a gene annotation, enabling identification of novel putatively functional elements including lncRNAs. Application on a breast cancer data set suggests considerably better performance than other DNA/RNA integration tools.
Insights
FocalScan identifies cancer driver genes by analyzing focal copy number alterations and gene expression changes. This novel tool improves the detection of cancer-driving genes, including novel elements like lncRNAs.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Somatic genomic copy-number alterations (CNAs) are crucial in cancer development, affecting tumor suppressor and driver genes.
- Identifying specific genes targeted by focal CNAs remains a significant challenge in cancer research.
- Existing methods integrating copy number and gene expression data lack sufficient specificity.
Purpose of the Study:
- To develop a novel computational tool, FocalScan, for identifying cancer driver and suppressor genes.
- To simultaneously analyze focal copy number alterations and coordinated gene expression changes.
- To improve the accuracy and specificity of targeted gene identification in cancer.
Main Methods:
- FocalScan integrates copy number alteration data with RNA sequencing (RNA-seq) expression data.
- The tool analyzes patterns of focal CNAs and coordinated expression changes across the genome.
- FocalScan can operate without prior gene annotation, enabling the discovery of novel functional elements.
Main Results:
- FocalScan successfully ranks potential cancer driver and suppressor genes.
- The tool demonstrated superior performance compared to existing DNA/RNA integration tools on a breast cancer dataset.
- FocalScan identified novel putatively functional elements, including long non-coding RNAs (lncRNAs).
Conclusions:
- FocalScan offers a powerful new approach for identifying cancer-driving genes by combining CNA and expression data.
- The tool's ability to scan the genome without annotation expands the discovery of novel cancer-related elements.
- FocalScan represents a significant advancement in cancer genomics research and precision oncology.
